Articles

Find an Article

Filter articles

Applied Filters

Showing 301 to 309 of 309 results

Clinical trials in BioPharma

US01-05-2011Eric Steffe

A recent study revealed that biotechnology companies or universities discovered 42 percent of all innovative drugs approved by the US Food and Drug Administration (FDA) between 1998 and 2007.

Clinical trials and stratified medicine—maximising patent exclusivity

01-05-2011Richard Korn and Stephanie Pilkington

The traditional business model for a new drug relies on a substantial period of market exclusivity to recoup extensive research and development costs.

US Patent Law changes appear imminent

US01-05-2011John Pegram and Mark Ellinger

US patent reform looks like it may finally be coming. John Pegram and Mark Ellinger explain the proposed changes.

Patenting genes and diagnostics

US01-05-2011Simon O’Brien and David Gass

As biotechnology patents continue to grow in importance, uncertainty remains on both sides of the Atlantic as to exactly what is patentable. Simon O’Brien and David Gass take a look.

Attacking the validity of selection patents

Canada01-05-2011Katie Wang

The Canadian Federal Court of Appeal recently considered whether ‘invalid selection’ can be an independent ground for invalidating selection patents. Katie Wang looks at the implications.

The Brazilian pharmaceutical sector: a year in review

Brazil01-05-2011Otto Licks and Anderson Nascimento

Practitioners can take heart from recent developments in the Brazilian courts, say Otto Licks and Anderson Nascimento.

Recognising equivalence, reciprocity and respect

Canada, Mexico, US01-05-2011Hedwig Lindner and Manuel Morante

Homologation (recognition of equivalence) is a useful tool for simplifying administrative processes that are repeated in different countries. Nevertheless, it is not an end in itself.

Myriad issues for gene patents

US01-05-2010

A recent US district court ruling could significantly affect companies that patent genes and threaten the health of an entire industry. LSIPR investigates.

Stricter examination requirements in Canada

Canada01-05-2010Katie Wang

Two pharmaceutical cases highlight recent developments in Canadian patent law relating to duty of candour during patent prosecution and patent claim construction, says Katie Wang.

Showing 301 to 309 of 309 results

LSIPR